Metraipolis › archive › dc_fc10c78d617e
Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41599182
- DOI
- 10.3390/pharmaceutics18010075
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:03:20.285Z
- SHA-256 of the archived text
94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a- Stable URL of this page
https://metraipolis.com/documento/dc_fc10c78d617e
How to cite
Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182 — Europe PMC (en), https://europepmc.org/article/MED/41599182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc10c78d617e (Metraipolis archive dc_fc10c78d617e, sha256 94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a)
BibTeX
@misc{dcfc10c78d617e,
title = {Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41599182},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc10c78d617e; sha256 94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599182. Agents can read the archived copy with the MCP tool read_document.